 lncRNA targets the enhancer region and positively regulates the gene expression. |
| lncRNA targets the promoter region and positively regulates the gene expression. |
| lncRNA targets the promoter region and negatively regulates the gene expression. |
| lncRNA targets the 3'UTR region and negatively regulates the mRNA. |
| Only predicted by lncTar | | UBL5,PPP2R3C,PCGF1,RPL35,CHKB,RRAS,NXT1,CSNK2B,ELOC,ARL6IP4,LUC7L,C19orf53,PFDN5,ELK3,TRAPPC2B,PRAF2,PPP1R35,DDX39A,UCHL3,TRIR,TIMM9,RPP30,LUC7L3,RHOJ,MIER2,SCNM1,KATNBL1,PFDN6,VKORC1,PFDN2,NDUFV2,RANGRF,RPL35A,NDUFB8,LGALS1,PFDN4,ILKAP | | Exist in public source | | NA |
| lncRNA targets the skipped exon region. | | -lncRNA and exonskipping events are positively correlated. |
 |
| LncRNA Ensembl ID | LncRNA ENST ID | Exon ID | Skipped Exon | dG | ndG | Gene name with skipped exon | TransID with skipped exon | ORF mutation | | ENSG00000266036 | ENST00000585285 | exon_skip_37475 | chr1:225504990-225505053 | -7.19 | -0.1383 | ENAH | ENST00000366844 | In-frame | | ENSG00000266036 | ENST00000585285 | exon_skip_44998 | chr10:110132304-110132400 | -11.13 | -0.1464 | ADD3 | ENST00000356080 | In-frame | | ENSG00000266036 | ENST00000585285 | exon_skip_384879 | chr3:52554723-52554879 | -25.57 | -0.1739 | PBRM1 | ENST00000296302 | In-frame | | ENSG00000266036 | ENST00000585285 | exon_skip_423795 | chr4:55888887-55888932 | -9.43 | -0.2858 | EXOC1 | ENST00000346134,ENST00000381295 | In-frame | | ENSG00000266036 | ENST00000585285 | exon_skip_461111 | chr6:90544551-90544632 | -13.01 | -0.1971 | MAP3K7 | ENST00000369329 | In-frame | | ENSG00000266036 | ENST00000585285 | exon_skip_499771 | chr9:128592982-128593042 | -14.16 | -0.2529 | SPTAN1 | ENST00000372731 | In-frame | | ENSG00000266036 | ENST00000585285 | exon_skip_111863 | chr14:23565815-23565892 | -14.49 | -0.2013 | AP1G2 | ENST00000308724,ENST00000397120 | Frame-shift | | ENSG00000266036 | ENST00000585285 | exon_skip_324294 | chr2:27774423-27774530 | -12.80 | -0.4741 | MRPL33 | ENST00000296102 | Frame-shift | | ENSG00000266036 | ENST00000585285 | exon_skip_353131 | chr20:58669290-58669453 | -32.38 | -0.2103 | STX16 | ENST00000371141 | Frame-shift | | ENSG00000266036 | ENST00000585285 | exon_skip_382458 | chr3:38131595-38131638 | -10.23 | -0.2436 | ACAA1 | ENST00000333167 | Frame-shift | | ENSG00000266036 | ENST00000585285 | exon_skip_434332 | chr5:34813573-34813660 | -11.33 | -0.1531 | RAI14 | ENST00000265109,ENST00000428746,ENST00000503673 | In-frame | | ENSG00000266036 | ENST00000585285 | exon_skip_53559 | chr10:101793912-101793998 | -13.37 | -0.2057 | OGA | ENST00000361464 | Frame-shift | | ENSG00000266036 | ENST00000585285 | exon_skip_326741 | chr2:73946718-73946906 | -20.82 | -0.1176 | DGUOK | ENST00000264093 | Frame-shift | | ENSG00000266036 | ENST00000585285 | exon_skip_67074 | chr11:406842-406993 | -28.52 | -0.2052 | SIGIRR | ENST00000332725,ENST00000397632,ENST00000431843 | Frame-shift | | ENSG00000266036 | ENST00000585285 | exon_skip_386291 | chr3:108050577-108050602 | -5.34 | -0.7629 | CD47 | ENST00000361309 | Frame-shift | | ENSG00000266036 | ENST00000585285 | exon_skip_516535 | chrX:119840645-119840684 | -5.86 | -0.2930 | UPF3B | ENST00000276201 | In-frame | | ENSG00000266036 | ENST00000585285 | exon_skip_5818 | chr1:45568484-45568684 | -21.50 | -0.1201 | AKR1A1 | ENST00000351829,ENST00000372070 | Frame-shift | | ENSG00000266036 | ENST00000585285 | exon_skip_140339 | chr16:635611-635774 | -27.18 | -0.1999 | METTL26 | ENST00000301686 | Frame-shift | | ENSG00000266036 | ENST00000585285 | exon_skip_52891 | chr10:98429790-98429889 | -23.09 | -0.2537 | HPS1 | ENST00000325103,ENST00000361490 | In-frame |
| -lncRNA and exonskipping events are negatively correlated. |
| LncRNA Ensembl ID | LncRNA ENST ID | Exon ID | Skipped Exon | dG | ndG | Gene name with skipped exon | TransID with skipped exon | LOF | | ENSG00000266036 | ENST00000585285 | exon_skip_361434 | chr21:25997359-25997416 | -12.93 | -0.5622 | APP | ENST00000346798 | In-frame |
| lncRNA targets by miRNA. |
| LncRNA Ensembl ID | miRNA ID | LncRNA ENST ID | Binding site in lncRNA | Score | Energy | Align Len | Public source |
| RNA A-to-I editing events in lncRNA. |
| LncRNAediting ID | LncRNA Ensembl ID | Chromosome | Editing Position | Strand | Gene Type | Gene Name | Transcript ID | Transcript Type | Transcript Name |
| Edited-associated DElncRNAs in cancer. |
| LncRNA Ensembl ID | LncRNA Index | Cancer Type | Chr_Postion_Strand | AVE1 | AVE2 | log2FC | W-value | P-value | Adjc.p-value | Change |
| Correlation between RNA A-to-I editing events's frequecy and lncRNA expression. |
| LncRNA Ensembl ID | LncRNA Index | Correlation | P-value | Adjc.p-value |
| Cis-expression quantitative trait loci(cis-eQTL) of lncRNA. |
| LncRNA Ensembl ID | LncRNA Name | SNP info | Number of Positive corelated Cancer | Positive corelated Cancer | Number of Negative corelated Cancer | Negative corelated Cancer |
| lncRNA regulates differentially expressed genes by function as enhancer. |
| LncRNA Ensembl ID | PC Gene ID | PC Gene Name | Positive correlated cancers | Cancer with PC gene up-regulation | Cancer with PC gene down-regulation |
| LncRNA-TF complex positively regulates the gene expression by target promoter region (#cancer types with positive correlation >= 5). |
| lncRNA ID | TF ID | TF Name | PCgene ID | PCgene Name | Number of Cancer | Canaer Types |
| LncRNA-TF complex negatively regulates the gene expression by target promoter region (#cancer types with negative correlation >= 5). |
| lncRNA ID | TF ID | TF Name | PCgene ID | PCgene Name | Number of Cancer | Canaer Types |
| LncRNA-RBP complex positively regulates the exon skippping events by target skipped eoxon region. |
| LncRNA Ensembl ID | RBP ID | RBP Gene Name | Exon Skipping ID | Skipped Exon | EX Gene Name | EX Affected TransID | ORF_anno | Cancer Type |
| LncRNA-RBP complex negatively regulates the exon skippping events by target skipped eoxon region. |
| LncRNA Ensembl ID | RBP ID | RBP Gene Name | Exon Skipping ID | Skipped Exon | EX Gene Name | EX Affected TransID | ORF_anno | Cancer Type |
| lncRNA regulates differential expressed mRNA by directly targeting 3' UTR region. |
| LncRNA Ensembl ID | LncRNA ENST ID | PC Gene Name | PC Gene ID | PC ENST ID | dG | nDG | Cancer with PC gene up-regulation | Cancer with PC gene Down-regulation | | ENSG00000266036 | ENST00000585285 | LUC7L | ENSG00000007392 | ENST00000426094 | -0.1096 | 13 | READ | - | | ENSG00000266036 | ENST00000585285 | LUC7L | ENSG00000007392 | ENST00000397783 | -0.1021 | 57 | READ | - | | ENSG00000266036 | ENST00000585285 | LUC7L | ENSG00000007392 | ENST00000429378 | -0.1034 | 162 | READ | - | | ENSG00000266036 | ENST00000585285 | LUC7L | ENSG00000007392 | ENST00000442701 | -0.1618 | 3 | READ | - | | ENSG00000266036 | ENST00000585285 | LUC7L | ENSG00000007392 | ENST00000397780 | -0.2258 | 18 | READ | - | | ENSG00000266036 | ENST00000585285 | PFDN5 | ENSG00000123349 | ENST00000551018 | -0.1926 | 112 | GBM | CESC | | ENSG00000266036 | ENST00000585285 | PFDN5 | ENSG00000123349 | ENST00000351500 | -0.1926 | 112 | GBM | CESC | | ENSG00000266036 | ENST00000585285 | PFDN5 | ENSG00000123349 | ENST00000550846 | -0.1926 | 112 | GBM | CESC | | ENSG00000266036 | ENST00000585285 | PFDN5 | ENSG00000123349 | ENST00000243040 | -0.1045 | 131 | GBM | CESC | | ENSG00000266036 | ENST00000585285 | PFDN5 | ENSG00000123349 | ENST00000334478 | -0.1926 | 112 | GBM | CESC | | ENSG00000266036 | ENST00000585285 | PFDN5 | ENSG00000123349 | ENST00000549759 | -0.2019 | 69 | GBM | CESC | | ENSG00000266036 | ENST00000585285 | RPL35A | ENSG00000182899 | ENST00000448864 | -0.1141 | 202 | GBM | - | | ENSG00000266036 | ENST00000585285 | RPL35A | ENSG00000182899 | ENST00000429437 | -0.1001 | 11 | GBM | - | | ENSG00000266036 | ENST00000585285 | NXT1 | ENSG00000132661 | ENST00000254998 | -0.1058 | 393 | GBM,COAD,READ | - | | ENSG00000266036 | ENST00000585285 | RPL35 | ENSG00000136942 | ENST00000373570 | -0.1681 | 1 | GBM | - | | ENSG00000266036 | ENST00000585285 | RPL35 | ENSG00000136942 | ENST00000493018 | -0.1026 | 1 | GBM | - | | ENSG00000266036 | ENST00000585285 | RPL35 | ENSG00000136942 | ENST00000348462 | -0.2738 | 304 | GBM | - | | ENSG00000266036 | ENST00000585285 | UBL5 | ENSG00000198258 | ENST00000586895 | -0.2046 | 245 | GBM | - | | ENSG00000266036 | ENST00000585285 | UBL5 | ENSG00000198258 | ENST00000358666 | -0.1500 | 244 | GBM | - | | ENSG00000266036 | ENST00000585285 | UBL5 | ENSG00000198258 | ENST00000590068 | -0.1500 | 244 | GBM | - | | ENSG00000266036 | ENST00000585285 | UBL5 | ENSG00000198258 | ENST00000593087 | -0.1101 | 246 | GBM | - | | ENSG00000266036 | ENST00000585285 | RRAS | ENSG00000126458 | ENST00000246792 | -0.1160 | 1 | GBM | CESC,LUSC | | ENSG00000266036 | ENST00000585285 | RHOJ | ENSG00000126785 | ENST00000316754 | -0.1365 | 1 | GBM | CESC,LUSC,BRCA |
| lncRNA regulates mRNA by competing the miRNA binding site with mRNA. |
| LncRNA Ensembl ID | lncRNA-miRNA-mRNA | Cancer Types |
| ORFfinder result for the gencode.v22.lncRNA.transcript.fa. |
| lncRNA Ensembl ID | lncRNA ENST ID | length(AA) | start at transcript | end at transcript | | ENSG00000266036.1 | ENST00000585285.1 | 93 | 391 | 110 |
|
